The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: A meta-analysis of prospective cohort studies

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Yang, Wan Shui ^a,b,c   Va, Puthiery ^d   Bray, Freddie ^e   Gao, Shan ^b,c   Gao, Jing ^b,c   Li, Hong Lan ^b,c   Xiang, Yong Bing ^b,c  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d UNIVERSITY OF NEW ENGLAND   (United States)

^e INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURVIVAL; COHORT ANALYSIS; DATA BASE; DECOMPOSITION; DIABETES MELLITUS; HUMAN; LIVER CELL CARCINOMA; META ANALYSIS; PROGNOSIS; QUALITY CONTROL; RECURRENCE RISK; RISK REDUCTION; DISEASE FREE SURVIVAL; LIVER; LIVER TUMOR; MORTALITY; PATHOLOGY; PROSPECTIVE STUDY;

CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; DIABETES COMPLICATIONS; DISEASE-FREE SURVIVAL; LIVER; LIVER NEOPLASMS; PROSPECTIVE STUDIES; QUALITY CONTROL;

EID: 83755174365     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027326     Document Type: Article

References (94)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) GLOBOCAN 2008, cancer incidence and mortality worldwide: IARC Cancer Base No. 10 Lyon, France International Agency for Research on Cancer 2010. [http://globocan.iarc.fr]. Accessed 2 January, 2011.
2. Parkin DM, Bray F, Ferlay J, Pisani P, (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
3. Chen JG, Zhu J, Zhang YH, Zhu YR, Lu JH, (2005) [Evaluation of secular trend of liver cancer incidence in Qidong, Jiangsu province, 1973-2002]. Zhonghua Yi Xue Za Zhi 85: 3052-3056.
4. Jin F, Devesa SS, Chow WH, Zheng W, Ji BT, et al. (1999) Cancer incidence trends in urban shanghai, 1972-1994: an update. Int J Cancer 83: 435-440.
5. Lee CL, Hsieh KS, Ko YC, (2003) Trends in the incidence of hepatocellular carcinoma in boys and girls in Taiwan after large-scale hepatitis B vaccination. Cancer Epidemiol Biomarkers Prev 12: 57-59.
6. Altekruse SF, McGlynn KA, Reichman ME, (2009) Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 27: 1485-1491.
7. Hassan MM, Frome A, Patt YZ, El-Serag HB, (2002) Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States. J Clin Gastroenterol 35: 266-269.
8. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB, (2004) Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 127: 1372-1380.
9. Donadon V, Balbi M, Zanette G, (2009) Hyperinsulinemia and risk for hepatocellular carcinoma in patients with chronic liver diseases and Type 2 diabetes mellitus. Expert Rev Gastroenterol Hepatol 3: 465-467.
10. Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, et al. (2009) Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care 32: 287-294.
11. Rousseau MC, Parent ME, Pollak MN, Siemiatycki J, Diabetes mellitus and cancer risk in a population-based case-control study among men from Montreal, Canada. Int J Cancer 2006;118: 2105-2109.
12. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB, (2005) Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut 54: 533-539.
13. Hassan MM, Hwang LY, Hatten CJ, Swaim M, Li D, et al. (2002) Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 36: 1206-1213.
14. El-Serag HB, Richardson PA, Everhart JE, (2001) The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans. Am J Gastroenterol 96: 2462-2467.
15. La Vecchia C, Negri E, Decarli A, Franceschi S, (1997) Diabetes mellitus and the risk of primary liver cancer. Int J Cancer 73: 204-207.
16. Yu MC, Tong MJ, Govindarajan S, Henderson BE, (1991) Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. J Natl Cancer Inst 83: 1820-1826.
17. Chodick G, Heymann AD, Rosenmann L, Green MS, Flash S, et al. (2010) Diabetes and risk of incident cancer: a large population-based cohort study in Israel. Cancer Causes Control 21: 879-887.
18. Wang CS, Yao WJ, Chang TT, Wang ST, Chou P, (2009) The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses. Cancer Epidemiol Biomarkers Prev 18: 2054-2060.
19. Ogunleye AA, Ogston SA, Morris AD, Evans JM, (2009) A cohort study of the risk of cancer associated with type 2 diabetes. Br J Cancer 101: 1199-1201.
20. Torisu Y, Ikeda K, Kobayashi M, Hosaka T, Sezaki H, et al. (2007) Diabetes mellitus increases the risk of hepatocarcinogenesis in patients with alcoholic cirrhosis: A preliminary report. Hepatol Res 37: 517-523.
21. Lai MS, Hsieh MS, Chiu YH, Chen TH, (2006) Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection. Hepatology 43: 1295-1302.
22. Khan M, Mori M, Fujino Y, Shibata A, Sakauchi F, et al. (2006) Site-specific cancer risk due to diabetes mellitus history: evidence from the Japan Collaborative Cohort (JACC) Study. Asian Pac J Cancer Prev 7: 253-259.
23. Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, et al. (2006) Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 166: 1871-1877.
24. El-Serag HB, Tran T, Everhart JE, (2004) Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 126: 460-468.
25. Tazawa J, Maeda M, Nakagawa M, Ohbayashi H, Kusano F, et al. (2002) Diabetes mellitus may be associated with hepatocarcinogenesis in patients with chronic hepatitis C. Dig Dis Sci 47: 710-715.
26. Hung CH, Lee CM, Wang JH, Hu TH, Chen CH, et al. (2011) Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon-based antiviral therapy. Int J Cancer 128: 2344-2352.
27. Veldt BJ, Chen W, Heathcote EJ, Wedemeyer H, Reichen JH, et al. (2008) Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology 47: 1856-1862.
28. Di Costanzo GG, De Luca M, Tritto G, Lampasi F, Addario L, et al. (2008) Effect of alcohol, cigarette smoking, and diabetes on occurrence of hepatocellular carcinoma in patients with transfusion-acquired hepatitis C virus infection who develop cirrhosis. Eur J Gastroenterol Hepatol 20: 674-679.
29. Ioannou GN, Splan MF, Weiss NS, McDonald GB, Beretta L, et al. (2007) Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol 5: 938-945, 941-945.
30. Richardson LC, Pollack LA, (2005) Therapy insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer. Nat Clin Pract Oncol 2: 48-53.
31. Barone BB, Yeh HC, Snyder CF, Peairs KS, Stein KB, et al. (2008) Long term all-cause mortality in cancer patients with pre-existing diabetes mellitus: A systematic review and meta-analysis. JAMA 300: 2754-2764.
32. Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, et al. (2010) Diabetes and Cancer: A concesus report. Diabetes Care 33: 1674-1685.
33. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ, (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159: 1160-1167.
34. Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE, (2006) Diabetes mellitus and breast cancer: a retrospective population-based cohort study. Breast Cancer Res Treat 98: 349-356.
35. Rose DP, Haffner SM, Baillargeon J, (2007) Adiposity, the metabolic syndrome, and breast cancer in African-American and White American women. Endocr Rev 28: 763-777.
36. Snyder CF, Stein KB, Barone BB, Peairs KS, Yeh HC, et al. (2010) Does pre-existing diabetes affect prostate cancer prognosis? A systematic review. Prostate Cancer Prostatic Dis 13: 58-64.
37. Giovannucci E, (2001) Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 131: 3109S-20S.
38. Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Macdonald JS, et al. (2003) Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol 21: 433-40.
39. Yu H, Pardoll D, Jove R, (2009) STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 9: 798-809.
40. Mantovani A, Allavena P, Sica A, Balkwill F, (2008) Cancer-related inflammation. Nature 454: 436-44.
41. Park EJ, Lee JH, Yu GY, He G, Ali SR, et al. (2010) Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 140: 197-208.
42. Vander Heiden MG, Cantley LC, Thompson CB, (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324: 1029-1033.
43. Yun J, Rago C, Cheong I, Pagliarini R, Angenendt P, et al. (2009) Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science 325: 1555-1559.
44. Morss AS, Edelman ER, (2007) Glucose modulates basement membrane fibroblast growth factor-2 via alterations in endothelial cell permeability. J Biol Chem 282: 14635-44.
45. Clemmons DR, Maile LA, Ling Y, Yarber J, Busby WH, (2007) Role of the integrin alphaVbeta3 in mediating increased smooth muscle cell responsiveness to IGF-I in response to hyperglycemic stress. Growth Horm IGF Res 17: 265-70.
46. Radhakrishnan Y, Maile LA, Ling Y, Graves LM, Clemmons DR, (2008) Insulin-like growth factor-I stimulates Shc-dependent phosphatidylinositol 3-kinase activation via Grb2-associated p85 in vascular smooth muscle cells. J Biol Chem 283: 16320-31.
47. Renehan AG, Frystyk J, Flyvbjerg A, (2006) Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab 17: 328-36.
48. Denley A, Carroll JM, Brierley GV, Cosgrove L, Wallace J, et al. (2007) Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors. Mol Cell Biol 27: 3569-3577.
49. Zhang H, Pelzer AM, Kiang DT, Yee D, (2007) Down regulation of type I insulin-like growth factor receptor increases activity of breast cancer cells to insulin. Cancer Res 67: 391-397.
50. Pollak M, (2008) Insulin and insulin-like growth factor signaling in neoplasia. Nat Rev Cancer 8: 915-928.
51. Mardilovich K, Pankratz SL, Shaw LM, (2009) Expression and function of the insulin receptor substrate proteins in cancer. Cell Comm Signal 7: 14.
52. Payne JE, Meyer HJ, (1995) The influence of other disease upon the outcome of colorectal cancer patients. Aust N Z J Surg. 65: 398-402.
53. Van de Poll-Franse LV, Houterman S, Janssen-Heijnen ML, Dercksen MW, Coebergh JW, et al. (2007) Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer 120: 1986-1992.
54. Weiser MA, Cabanillas ME, Konopleva M, Pierce SA, et al. (2004) Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexatecytarabine regimen. 100: 1179-1185.
55. Huo TI, Hsu CY, Huang YH, Hsia CY, Lin HC, et al. (2010) Diabetes mellitus as an independent prognostic predictor and its association with renal dysfunction in patients with hepatocellular carcinoma. Liver Int 30: 198-207.
56. Lam EK, Batty GD, Huxley RR, Martiniuk AL, Barzi F, et al. (2011) Associations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific region. Ann Oncol 22: 730-738.
57. Kawamura Y, Ikeda K, Arase Y, Yatsuji H, Sezaki H, et al. (2008) Diabetes mellitus worsens the recurrence rate after potentially curative therapy in patients with hepatocellular carcinoma associated with nonviral hepatitis. J Gastroenterol Hepatol 23: 1739-1746.
58. Oba S, Nagata C, Nakamura K, Takatsuka N, Shimizu H, (2008) Self-reported diabetes mellitus and risk of mortality from all causes, cardiovascular disease, and cancer in Takayama: a population-based prospective cohort study in Japan. J Epidemiol 18: 197-203.
59. Komura T, Mizukoshi E, Kita Y, Sakurai M, Takata Y, et al. (2007) Impact of diabetes on recurrence of hepatocellular carcinoma after surgical treatment in patients with viral hepatitis. Am J Gastroenterol 102: 1939-1946.
60. Park SM, Lim MK, Shin SA, Yun YH, (2006) Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study. J Clin Oncol 24: 5017-5024.
61. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, et al. (2005) Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293: 194-202.
62. Huo TI, Wu JC, Lui WY, Huang YH, Lee PC, et al. (2004) Differential mechanism and prognostic impact of diabetes mellitus on patients with hepatocellular carcinoma undergoing surgical and nonsurgical treatment. Am J Gastroenterol 99: 1479-1487.
63. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ, (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159: 1160-1167.
64. Batty GD, Shipley MJ, Marmot M, Smith GD, (2004) Diabetes status and post-load plasma glucose concentration in relation to site-specific cancer mortality: findings from the original Whitehall study. Cancer Causes Control 15: 873-881.
65. Huo TI, Lui WY, Huang YH, Chau GY, Wu JC, et al. (2003) Diabetes mellitus is a risk factor for hepatic decompensation in patients with hepatocellular carcinoma undergoing resection: a longitudinal study. Am J Gastroenterol 98: 2293-2298.
66. Huo TI, Wu JC, Lui WY, Lee PC, Huang YH, et al. (2003) Diabetes mellitus is a recurrence-independent risk factor in patients with hepatitis B virus-related hepatocellular carcinoma undergoing resection. Eur J Gastroenterol Hepatol 15: 1203-1208.
67. Poon RT, Fan ST, Wong J, (2002) Does diabetes mellitus influence the perioperative outcome or long term prognosis after resection of hepatocellular carcinoma? Am J Gastroenterol 97: 1480-1488.
68. Fujino Y, Mizoue T, Tokui N, Yoshimura T, (2001) Prospective study of diabetes mellitus and liver cancer in Japan. Diabetes Metab Res Rev 17: 374-379.
69. Ikeda Y, Shimada M, Hasegawa H, Gion T, Kajiyama K, et al. (1998) Prognosis of hepatocellular carcinoma with diabetes mellitus after hepatic resection. Hepatology 27: 1567-1571.
70. Higgins JP, Thompson SG, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
71. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
72. Egger M, Davey SG, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
73. Begg CB, Mazumdar M, (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
74. Duval S, Tweedie R, (2000) Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56: 455-463.
75. Martin LM, Leff M, Calonge N, Garrett C, Nelson DE, (2000) Validation of self-reported chronic conditions and health services in a managed care population. Am J Prev Med 18: 215-218.
76. Wu SC, Li CY, Ke DS, (2000) The agreement between self-reporting and clinical diagnosis for selected medical conditions among the elderly in Taiwan. Public Health 114: 137-142.
77. Fuller JH, Elford J, Goldblatt P, Adelstein AM, (1983) Diabetes mortality: new light on an underestimated public health problem. Diabetologia 24: 336-341.
78. Landman GW, Kleefstra N, van Hateren KJ, Groenier KH, Gans RO, et al. (2010) Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16. Diabetes Care 33: 322-326.
79. Currie CJ, Poole CD, Gale EA, (2009) The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia 52: 1766-1777.
80. Monami M, Lamanna C, Pala L, Bardini G, Cresci B, et al. (2008) Treatment with insulin secretagogues and cancer-related mortality in type 2 diabetic patients a retrospective cohort study. Exp Clin Endocrinol Diabetes 116: 184-189.
81. Roden M, (2006) Mechanisms of disease: hepatic steotosis in type 2 diabtes-pathogenesis and clinical relevance. Nat Clin Pract Endocrinol Metab 2: 335-348.
82. Whitehead JP, Richards AA, Hickman Ij, Macdonald GA, Prins JB, (2006) Adiponectin-a key adipokine in metabolic syndrome. Diabetes Obe Metab 8: 264-280.
83. Jonsson JR, Moschen AR, Hickman IJ, Richardson MM, Kaser S, et al. (2005) Adiponectin and its receptors in patients with chronic hepatitis C. J Hepatol 43: 929-936.
84. Cheruvattath R, Balan V, (2007) Infections in patients with end-stage liver disease. J Clin Gastroenterol 41: 403-411.
85. Zhu AX, Chabner BA, Tanabe KK, (2010) New trends and novel treatment for hepatocellular carcinoma: A global perspective. Oncologist 15: 1-4.
86. Sanyal AJ, Yoon SK, Lencioni R, (2010) The etiology of hepatocellular carcinoma and consequences of treatment. Oncologist 15: 14-22.
87. Lau WY, Lai EC, (2008) Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis Int 7: 237-257.
88. Hoerger TJ, Segel JE, Gregg EW, Saaddine JB, (2008) Is glycemic control improving in U.S. Adults. Diabetes Care 31: 81-86.
89. Sanz C, Gautier JF, Hanaire H, (2010) Phsyical exercise for prevention and treatment of type 2 diabetes. Diabetes Metab 36: 346-351.
90. Cucchetti A, Zanello M, Cescon M, Ercolani G, Del GM, et al. (2011) Improved Diagnostic Imaging and Interventional Therapies Prolong Survival After Resection for Hepatocellular Carcinoma in Cirrhosis: The University of Bologna Experience Over 10 Years. Ann Surg Oncol 18: 1630-1637.
91. Shi M, Zhang CQ, Zhang YQ, Liang XM, Li JQ, (2004) Micrometastases of solitary hepatocellular carcinoma and appropriate resection margin. World J Surg 29: 376-381.
92. Wong IH, Yeo W, Leung T, Lau WY, Johnson PJ, (2001) Circulating tumor cell mRNAs in peripheral blood from hepatocellular carcinoma patients under radiotherapy, surgical resection or chemotherapy: a quantitative evaluation. Cancer Lett 167: 183-191.
93. Takiya L, Chawla S, (2002) Therapeutic options for the management of type 2 diabetes mellitus. Am J Manag Care 8: 1009-23; quiz 1024-7.
94. Feng YH, Lin CY, Huang WT, Wu CL, Fang JL, et al. (2010) Diabetes mellitus impairs the response to intra-arterial chemotherapy in hepatocellular carcinoma. Med Oncol DOI:10.1007/s12032-010-9650-9 (in press).